Clinical Trial Update: Treatment of MDEs During the Course of Psychotic Disorders With Duloxetine [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating duloxetine for major depressive episodes occurring during psychotic disorders has completed, assessing its safety and efficacy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Psychotic Disorders

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Psychotic Disorders | Phase 4 | Status: COMPLETED